Weight Loss Associated with Cholinesterase Inhibitors for Dementia (Journal of the American Geriatrics Society)


Research following persons with dementia aged 65 and older, between 2007 to 2010, compared weight loss in individuals prescribed cholinesterase inhibitors against weight loss in persons prescribed other medications.

Individuals taking cholinesterase inhibitors had a higher risk of weight loss. The risk of weight loss may need to be considered when prescribing cholinesterase inhibitors.

Full Text Link (Note: This article requires a suitable Athens password, a journal subscription or payment for access).


Sheffrin, MM. Miao, Y. [and] Boscardin, WJ. (2015). Weight Loss Associated with Cholinesterase Inhibitors in Individuals with Dementia in a National Healthcare System. Journal of the American Geriatrics Society. August 3rd 2015. [Epub ahead of print]. (Click here to view the PubMed abstract).

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, Management of Condition, Pharmacological Treatments, Universal Interest and tagged , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.